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ABSTRACT 
The product L-valine, feed grade (ValAMINO
®), is a feed additive produced by fermentation with a genetically 
modified strain of Corynebacterium glutamicum (DSM 25202). Neither the production strain nor its recombinant 
DNA was detected in the final product. Therefore, the final product does not give rise to any safety concerns 
with regard to the genetic modification. The additive L-valine, feed grade, produced by C. glutamicum (DSM 
25202) is safe for all target animals when supplemented in appropriate amounts to feed to compensate for valine 
deficiency in feedingstuffs. The composition of tissues and products of animal origin will not be changed by the 
use of L-valine, feed grade, in animal nutrition. Considering the high purity of the product under assessment, no 
risks to the consumer are expected from its use as a feed additive. In the absence of specific data on user safety 
for the product under application, it would be prudent to consider it as an irritant to the skin, eyes and mucous 
membranes and as a potential dermal sensitiser. In the absence of any data on inhalation toxicity, the product is 
also regarded as potentially harmful by inhalation. The amino acid L-valine is a natural component of proteins of 
living organisms. Therefore, the use of the highly purified product L-valine, feed grade, in animal nutrition does 
not pose a risk to the environment. The product L-valine, feed grade, is an efficacious source of supplemented 
amino acid for all species, but it has a low efficiency in ruminants unless it is used in a protected form. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on  L-valine 
(ValAMINO
®)  produced  by  fermentation  using  a  genetically  modified  strain  of  Corynebacterium 
glutamicum (DSM 25202), for all animal species. 
L-Valine is an essential amino acid that may become limiting under specific feeding conditions. Its 
supplementation  has  become  even  more  important since  protein-reduced  diets  were introduced in 
animal husbandry for economic and environmental reasons. In European vegetable feed formulas, L-
valine seems to be the fifth limiting amino acid after L-tryptophan in pigs for fattening and the fourth 
limiting amino acid after L-threonine in chickens for fattening. 
Neither the production strain nor its recombinant DNA was detected in the final product. Therefore, 
the final product does not give rise to any safety concerns with regard to the genetic modification. 
The additive  L-valine, feed grade, produced by C. glutamicum (DSM 25202) is safe for all target 
animals when supplemented in appropriate amounts to feed for a compensation of valine deficiency in 
feedingstuffs. 
The composition of tissues and products of animal origin will not be changed by the use of L-valine, 
feed grade, in animal nutrition. Considering the high purity of the product under assessment, no risks 
to the consumer are expected from its use as a feed additive. 
In the absence of any data, it would be prudent to consider L-valine produced by C. glutamicum (DSM 
25202) as an irritant to the skin, eyes and mucous membranes and as a potential dermal sensitiser. In 
the absence of any data on inhalation toxicity, the product is also regarded as potentially harmful by 
inhalation. 
The amino acid L-valine is a natural component of proteins of living organisms. Therefore, the use of 
the  highly  purified  product  L-valine,  feed  grade,  in  animal  nutrition  does  not  pose  a  risk  to  the 
environment. 
The product L-valine, feed grade, is an efficacious source of supplemented amino acid for all species, 
but it has a low efficiency in ruminants unless it is used in a protected form. 
The  FEEDAP  Panel  made  recommendations  regarding  the  description  of  the  additive  and  the 
microbial contamination. L-Valine (ValAMINO
®) for all animal species 
 
EFSA Journal 2014;12(7):3795  3 
TABLE OF CONTENTS 
Abstract .................................................................................................................................................... 1 
Summary .................................................................................................................................................. 2 
Table of contents ...................................................................................................................................... 3 
Background .............................................................................................................................................. 4 
Terms of reference.................................................................................................................................... 5 
Assessment ............................................................................................................................................... 7 
1.  Introduction ..................................................................................................................................... 7 
2.  Characterisation ............................................................................................................................... 7 
2.1.  Characterisation of the active substance/additive ........................................................................ 7 
2.2.  Impurities  ..................................................................................................................................... 8 
2.3.  Physical properties  ....................................................................................................................... 8 
2.4.  Characterisation of the production organism  ............................................................................... 8 
2.4.1.  Information relating to the genetically modified microorganism ....................................... 8 
2.4.2.  Information relating to the manufacturing process ............................................................. 9 
2.5.  Stability and homogeneity ........................................................................................................... 9 
2.5.1.  Shelf life ............................................................................................................................. 9 
2.5.2.  Stability in premixtures ...................................................................................................... 9 
2.5.3.  Stability in feedingstuffs  ..................................................................................................... 9 
2.5.4.  Homogeneity ...................................................................................................................... 9 
2.6.  Physico-chemical incompatibilities in feed ................................................................................. 9 
2.7.  Conditions of use ....................................................................................................................... 10 
2.8.  Evaluation of the analytical methods by the European Union Reference Laboratory (EURL)  . 10 
3.  Safety ............................................................................................................................................. 10 
3.1.  Safety aspects of the genetic modification ................................................................................ 10 
3.2.  Safety for the target species ....................................................................................................... 10 
3.2.1.  Conclusions on the safety for the target species ............................................................... 10 
3.3.  Safety for the consumer ............................................................................................................. 10 
3.3.1.  Conclusions on the safety for the consumer ..................................................................... 11 
3.4.  Safety for the user  ...................................................................................................................... 11 
3.5.  Safety for the environment ........................................................................................................ 11 
3.5.1.  Conclusions on the safety for the environment ................................................................ 11 
4.  Efficacy  .......................................................................................................................................... 11 
4.1.  Conclusions on efficacy ............................................................................................................ 12 
5.  Post-market monitoring ................................................................................................................. 12 
Conclusions and recommendations ........................................................................................................ 12 
Documentation provided to EFSA ......................................................................................................... 13 
References .............................................................................................................................................. 13 
Appendix ................................................................................................................................................ 14 L-Valine (ValAMINO
®) for all animal species 
 
EFSA Journal 2014;12(7):3795  4 
BACKGROUND 
Regulation  (EC)  No  1831/2003
4 establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7.  
The European Commission received a request from the com pany Evonik Industries AG, Heath and 
Nutrition
5 for authorisation of the product L-valine, ValAMINO
®, when used as a feed additive for all 
animal species (category: nutritional additive; functional group: amino acids, their salts and analogues) 
under the conditions mentioned in Table 1.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application  to  the  European  Food  Safety  Authority  (EFSA)  as  an  application  under  Article  4(1) 
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the 
applicant  the  technical  dossier  in  support  of  this  application.
6 According  to  Article  8  of  that 
Regulation, EFSA, after verifying the particulars and documents submitted by the applicant, shall 
undertake an assessment in order to determine whether the feed additive complies with the conditions 
laid down in Article 5. The particulars and documents in support of the application were considered 
valid by EFSA as of 8 May 2013. 
The additive  L-valine  (ValAMINO
®)  is  produced  using  a  genetically  modified  Corynebacterium 
glutamicum (DSM25202).  It has not been previously authorised as feed additive in the European 
Union.  
L-Valine  produced  by  Escherichia  coli  (AG314)  FERM  ABP-10640,  currently  authorised  as 
nutritional additive until 3
rd of June 2019,
7 was assessed by the EFSA FEEDAP Panel in 2008 (EFSA, 
2008a, b). EFSA FEEDAP Panel (2013) issued a scientific opinion on the safety and efficacy of L -
valine produced by Corynebacterium glutamicum (KCCM 80058) for all animal species. The safety of 
L-valine when used as food flavouring was assessed by Joint FAO/WHO Expert Committee on Food 
Additives (JECFA, 2006) and by the EFSA Panel on Food Additives, Flavourings, Processing Aids 
and Materials in contact with Food (AFC) (EFSA, 2008c). 
L-Valine  is  one  of the  substances listed  in  Annex III  of  Commission  directive  2006/141/EC  and 
therefore authorised for the manufacture of infant formulae and follow-on formulae in order to satisfy 
the requirements on amino acids and other nitrogen compounds, and in a “pharmaceutical” grade form 
it is used for parenteral nutrition.
8 It may also be added for specific nutritional purposes in foods for 
particular nutritional uses according to Commission Directive 2001/15/EC.
9 L-Valine and DL-valine 
are also authorised as sensory additives, belonging to the functional group flavouring compounds 
(FLAVIS No 17.028 and 17.023, respectively).
10 L-Valine has a dedicated monograph in the European 
Pharmacopoeia (EurPh).
11 
                                                       
4  Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5  Evonik Industries AG, Health and Nutrition (Rodenbacher Chausse 4, 63457, Hanau-Wolfgang, Germany). 
6  EFSA dossier reference: FAD-2011-0053. 
7  Commission Regulation (EC) 403/2009 of 14 May 2009 concerning the authorisation of a preparation of L -valine as feed 
additive. OJ L 120, 15.5.2009, p. 2. 
8  Commission Directive 2006/141/EC on infant formulae and follow-on formulae. OJ L 401, 30.12.2006, p. 1–33. 
9  Commission Directive 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes 
in foods for particular nutritional uses. OJ L 52, 22.2.2001, p. 1–7. 
10 Commission list of the authorised additives in feedingstuffs published in application of Article 9t (b) of Council Directive 
70/524/EEC concerning additives in feedingstuffs (2004/C 50/01) OJ C 50, 25.2.2004, p. 1–144. 
11 European Pharmacopoeia monograph 01/2008: 0796, correction 6.0. L-Valine (ValAMINO
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TERMS OF REFERENCE 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of the product L-
valine  (ValAMINO
®)  produced  by  the  genetically  modified  strain  Corynebacterium  glutamicum 
(DSM 25202), when used under the conditions described in Table 1. L-Valine (ValAMINO
®) for all animal species 
 
EFSA Journal 2014;12(7):3795  6 
Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive   L-Valine Feed Grade 
Registration number/EC 
No/No (if appropriate)  3c.3.7.1 
Category(-ies) of additive  Nutritional Additives 
Functional group(s) of additive  Amino Acids, Salts and Analogues 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
> 98.0%  C5H11NO2  > 98.0% on dry matter  Reg,(EC)No. 152/2009 
 
Trade name (if appropriate)  ValAMINO 
Name of the holder of 
authorisation (if appropriate)  Evonik Industries AG 
 
Conditions of use 
Species  or 
category  of 
animal 
Maximum 
Age 
Minimum content  Maximum content  Withdrawal 
period 
(if appropriate)  mg/kg of complete feedingstuffs 
All animal species  All ages  Not applicable  Not applicable  Not applicable 
 
Other provisions and additional requirements for the labelling 
Specific conditions or restrictions for 
use (if appropriate)  Not applicable 
Specific conditions or restrictions for 
handling (if appropriate)  Not applicable 
Post-market monitoring  
(if appropriate)  Not applicable 
Specific conditions for use in 
complementary feedingstuffs  
(if appropriate) 
Not applicable 
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
Not applicable  Not applicable  Not applicable  Not applicable L-Valine (ValAMINO
®) for all animal species 
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ASSESSMENT 
This  opinion  is  based  in  part  on  data  provided  by  a  single  company  involved  in  the 
production/distribution of L-valine. It should be recognised that these data cover only a fraction of the 
existing additives containing  L-valine. The Panel on Additives and Products or Substances used in 
Animal Feed (FEEDAP) has sought to use the data provided together with data from other sources to 
deliver an opinion. 
1.  Introduction 
L-Valine  (ValAMINO
®)  is  obtained  by  fermentation  using  a  genetically  modified  strain  of 
Corynebacterium glutamicum (DSM25202). The product under application is intended to be used in 
feed  for  all  animal  species  and  categories  without  restrictions  in  maximum  content  or  time  of 
administration. 
L-Valine is an essential proteogenic amino acid belonging, along with leucine and isoleucine, to the 
group of branched-chain amino acids. The objective of feed supplementation with essential amino 
acids is to complete the amino acid profile of the diet in order to closely meet the requirement for 
individual amino acids of the animals. The supplementation of feedingstuffs with amino acids is a 
conventional measure in improving protein quality and utilisation. This supplementation has become 
even more important since protein-reduced diets were introduced in animal husbandry for economic 
and environmental reasons. It is well recognised that valine, as an essential amino acid, may become 
limiting under specific feeding conditions. 
2.  Characterisation 
The FEEDAP Panel notes that all data necessary to characterise the product are based on pilot batches, 
since industrial large-scale production has not yet started. The data can be taken as representative of 
the commercial product only if large-scale manufacturing were to apply the same fermentation and 
purification criteria as used for the pilot products. Consequently, the following assessment would 
apply only if these conditions are met. 
2.1.  Characterisation of the active substance/additive 
L-Valine  (International  Union  of  Pure  and  Applied  Chemistry  (IUPAC)  name:  (2S)-2-amino-3-
methylbutanoic acid; synonyms: α-aminoisovaleric acid, 2-amino-3-methylbutyric acid), a compound 
that is identified by the Chemical Abstracts Service (CAS) No 72-18-4 and the European Inventory of 
Existing  Commercial  Chemical  Substances  (EINECS)  No  200-773-6,  has  a  molecular  weight  of 
117.15 g/mol; the molecular formula is C5H11NO2 and its structural formula is given in Figure 1. 
 
Figure 1:   Molecular structure of valine 
The product is specified to contain no less than 98 % L-valine on a dry matter basis. Analysis of five 
batches  by  the  official  method  ((EC)  152/2009)  showed  a  valine  content  ranging  from  99.19  to 
99.87 % on an as is basis. Water loss on drying was between 0.04 and 0.07 %. The sum of other amino 
acids (glycine, alanine, isoleucine, leucine, tyrosine, phenylalanine and lysine) amounted to ≤ 0.59 % L-Valine (ValAMINO
®) for all animal species 
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and ash was ≤ 0.04 %, both on as is basis.
12 The specific optical rotation measured on three batches 
was from +  27.4   to + 27.6   (25  C, 6N HCl) and thus within the range set in the European 
Pharmacopoeia for the L-enantiomer of valine.
13 
2.2.  Impurities 
The applicant provided analytical data on heavy metals (mercury, cadmium and lead), arsenic and 
non-dioxin-like  polychlorinated  biphenyls  (PCBs)  in  five  pilot  batches.  Dioxins  (polychlorinated 
dibenzodioxins (PCDDs)/polychlorinated dibenzofurans (PCDFs)) were measured in four batches and 
dioxin-like PCBs were measured in three batches of the additive.
14 The detected amounts of all these 
impurities were very low, often below the detection limits, and therefore were of no  safety concern.
15 
Aflatoxins B1, B2, G1 and G2 and ochratoxin A were not detected in three batches (analytical 
methods and limit of detection (LOD) not given).
16 Trace amounts of aluminium, chromium, copper, 
iron and zinc were also found in the product. 
Three pilot batches of the additive showed unacceptably high levels of microbial contamination. 
Aerobic  spore  formers  were  2.6  × 10
4,  6.8 × 10
4  and  1.2 × 10
5  colony-forming  units  (CFU)/g; 
Salmonella spp. were not detected (in 25 g samples) and Enterobacteriaceae, Escherichia coli, yeasts 
and moulds were below 100 CFU/g.
17 
2.3.  Physical properties 
The product is a white crystalline powder. Mean analytical values from three batches showed a density 
of 1.26 g/cm
3 and a bulk density of 0.34 g/cm
3. Solubility in water is 58.6 g/L at 20  C and pH 5.4 of a 
10 % solution in water.
18 
The mean particle size obtained by sieving of four batches was 42  m (range 38–50  m). The average 
proportion of particles < 32  m diameter was 33 % (range 28–38 %).
19 Dustiness was determined in 
two batches of the additive using an in -house optical method of the applicant. The figures 84 and 
86 %rel indicate a high dusting potential of the product (0 %rel means no dust, 100 %rel means saturated 
dust).
20 
2.4.  Characterisation of the production organism 
L-Valine is produced by a genetically modified strain of C. glutamicum which is deposited in the 
German Collection of Microorganisms and Cell Cultures (DSMZ) with the deposition number DSM 
25202.
21 Its taxonomy was confirmed by the DSMZ based on morphological , physiological and 
chemotaxonomic analyses, ribotyping and sequencing of 16S rRNA genes.
22 
2.4.1.  Information relating to the genetically modified microorganism
23  
The  dossier  contains  detailed  and  sufficient  information  on  the  recipient  strain  including  safety 
aspects, the origin and function of the different genetic elements introduced in the production strain, 
the genetic modification process and the genetic and phenotypic traits introduced. 
                                                       
12 Supplementary information July 2013/Section II/Annexes II.4 and II.8. 
13 Supplementary information July 2013/Section II/Annex II.27. 
14 Supplementary information July 2013/Section II/Annexes II.9 to II.17. 
15 LOD (mg/kg) of cadmium and mercury = 0.01, of arsenic = 0.05, of lead = 0.1 and of PCBs = 0.001. The sum of toxicity 
equivalent (WHO-TE) PCDD/PCDF ranged from 0.008 to 0.096 ng/kg in the six batches analysed. 
16 Supplementary information July 2013/Section II/Annex II.21. 
17 Supplementary information July 2013/Section II/Annex II.21. 
18 Supplementary information July 2013/Annexes II.26, and II.28 to II.30. 
19 Technical dossier/Section II.2.1.5/Annex II.18. 
20 Technical dossier/Section II.2.1.5/Annex II.17 and Reference 5. 
21 Technical dossier/Section II/Annex II.16 and supplementary information July 2013/Section II/Annex II.20. 
22 Supplementary information July 2013/Section II.2.2.1.2. 
23   This section has been edited following the confidentiality claims made by the applicant. L-Valine (ValAMINO
®) for all animal species 
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2.4.2.  Information relating to the manufacturing process
24 
L-Valine  is  produced  by  fermentation  with  C.  glutamicum  (DSM  25202).  After  the  fermentation 
process, purification and isolation of the active substance follows. 
25 Material safety data sheets for 
fermentation media used in the production and for the final product are provided.
26 
Neither the production strain nor its recombinant DNA could detected in three pilot batches of the 
final product.
27 
2.5.  Stability and homogeneity 
2.5.1.  Shelf life 
The shelf life of the product was studied in three batches when stored at 10–25  C in paper bags with a 
polyethylene (PE) liner for two years, or at 45, 60 and 85  C for three months, three weeks and three 
days, respectively. No losses were observed at ambient temperature for two years or at 45  C for three 
months. At 60  C for three weeks, the maximum losses were up to 2 %, whereas no losses occurred in 
the product stored at 85  C for three days.
28 
2.5.2.  Stability in premixtures 
The stability of the additive (three batches) was tested in a vitamin (without choline chloride)–mineral 
premixture for poultry containing 50 % L-valine. After storage in paper bags with a PE liner at 10–
25  C for six months, the losses were between 0 and 9 %.
29 
2.5.3.  Stability in feedingstuffs 
One batch of the product was tested for stability in three different complete feeds: a pelleted pre-starter 
diet for chickens for fattening, a pelleted pre-starter diet for piglets and a mash starter diet for piglets, 
all of which were based on maize and soy bean meal (L-valine supplemented at levels of 0.10, 0.15 
and 0.10 %, respectively). The feedingstuffs packed in paper bags with a PE liner were stored at 10–
25  C for three months. No losses were observed in any of the feedingstuffs after three months of 
storage.
30 However, the data submitted were insufficient to assess the stability of the additive durin g 
feed processing. 
2.5.4.  Homogeneity 
The capacity of the additive to homogeneously distribute was tested with three L-valine batches in the 
vitamin–mineral premixture for poultry (10 subsamples, supplementation level 50 %). The coefficient 
of  variation  (CV)  ranged  from  4.5  to  7.7 %.  In  the  piglet  starter  mash  feed  (10  subsamples, 
supplementation with one batch of L-valine at 0.10 %) the CV for valine was 3.7 %. 
2.6.  Physico-chemical incompatibilities in feed 
No physico-chemical incompatibilities in feed are expected when used with other additives, medicinal 
products or other feed materials. 
                                                       
24   This section has been edited following the confidentiality claims made by the applicant. 
25 Supplementary information July 2013/Section II.2.3.1. 
26 Supplementary information July 2013/Section II.2.3.1 and Annexes II.32 to II.41; and technical dossier/Section II/Annex 
II.19. 
27 Supplementary information November 2013/Annex 1 and supplementary information July 2013/Section II/Annex II.22 ; 
supplementary information November 2013/Annex 2. 
28 Technical dossier/Section II.2.4.1./Annexes II.20 and II.21, and supplementary information July 2013/Annex II.42 and 
II.43. 
29 Technical dossier/Section II.2.4.1.2/Annex II.22 and supplementary information July 2013/Section II/Annex II.44. 
30 Technical dossier/Section II.2.4.1.2/Annex II.23 and supplementary information July 2013/Section II/Annex II.45. L-Valine (ValAMINO
®) for all animal species 
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2.7.  Conditions of use 
The additive L-valine, feed grade, is intended to be used for all animal species and categories with no 
minimum  or  maximum  content  specified.  It  is  proposed  to  be  supplemented  in  feedingstuffs  via 
premixtures or directly into complete feed and complementary feed. The level of supplementation will 
depend on the dietary composition and animal requirements. 
2.8.  Evaluation of the analytical methods by the European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of  L-valine in 
animal feed. The Executive Summary of the EURL report can be found in Appendix A. 
3.  Safety 
3.1.  Safety aspects of the genetic modification
31 
The parental strain is considered to be safe. The applicant provided sufficient information to show that 
neither the production strain nor the recombinant genes are present in the final product. Therefore, the 
presence of recombinant genes in the production strain does not give rise to safety concerns. 
3.2.  Safety for the target species 
Tolerance studies are not normally required for highly purified amino acids. Such tolerance studies 
with  a  certain  indispensable  amino  acid  will  inevitably  result  in  amino  acid  imbalances,  with  a 
depression of feed intake and hence impaired performance and higher nitrogen excretion per quantity 
of animal product. This is also the case for the additive under application, which contains > 99 % 
valine and less than 1 % unidentified material on a dry matter basis. Therefore, the FEEDAP Panel 
considers that safety concerns for the target species are highly unlikely to arise from the use of this 
additive. 
The requirements of the target animal species for valine and the safety of the use of this essential 
amino acid in animal nutrition were recently summarised in an opinion of the FEEDAP Panel (EFSA 
FEEDAP Panel, 2013). The previous opinion did not include requirements of fish for valine, which 
range from 0.7 to 1.6 % depending on the fish species (for a detailed review, see NRC, 2011). 
3.2.1.  Conclusions on the safety for the target species 
The FEEDAP Panel concludes that additive L-valine produced by C. glutamicum (DSM 25202) is safe 
for all target animal species when supplemented in appropriate amounts to the diet. Excess doses 
would create amino acid imbalances with negative consequences for animal performance and nitrogen 
excretion. 
3.3.  Safety for the consumer 
Absorption, distribution, metabolism and excretion of the amino acid L-valine have been described in 
a recent scientific opinion of EFSA (EFSA FEEDAP Panel, 2013). 
Amino acids supplemented in feed will be incorporated into proteins of tissues and/or products of 
target animal species and any of their potential excess will be metabolised and excreted as urea/uric 
acid and carbon dioxide. Therefore, the composition of tissues and products of animal origin will not 
be changed by the use of L-valine, feed grade, in animal nutrition. 
No  specific  toxicological  studies  were  submitted  for  the  product  under  assessment.  As  a  general 
principle, conventional toxicology studies are considered to be inappropriate for amino acids. Dietary 
intakes of amino acids that lead to amounts significantly below or above that which is optimum for 
                                                       
31   This section has been edited following the confidentiality claims made by the applicant. L-Valine (ValAMINO
®) for all animal species 
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health and performance will inevitably cause a physiological imbalance and, consequently, adverse 
effects. 
The product under assessment is produced by fermentation. Concerns for the consumer would arise 
not from the amino acid itself, but from possible residues from the fermentation. Considering the high 
purity of the product under assessment, no risks are expected for the consumer from the use of  L-
valine, feed grade, produced by C. glutamicum (DSM25202) as a feed additive. 
3.3.1.  Conclusions on the safety for the consumer 
The use of L-valine, feed grade, produced by C. glutamicum (DSM25202) in animal nutrition gives 
rise to no concern for the safety of the consumer. 
3.4.  Safety for the user 
The data submitted by the applicant refer only to REACH documentation on L-valine, with a specified 
purity of > 98 % (ECHA database on REACH).
32 
No specific studies were submitted for the product under assessment and therefore the FEEDAP Panel 
considers it to be a potential skin and eye irritant and dermal sensitiser. Given the particle size 
distribution (up to 33 % particles are < 32  m) and the high dusting potential, user exposure to the 
product by inhalation cannot be excluded. In the absence of any data on inhalation toxicity, the 
product has to be regarded as potentially harmful by inhalation. 
3.5.  Safety for the environment 
Neither the production strain nor its recombinant DNA was detected in the final product. Therefore, 
the additive L-valine does not give rise to an environmental safety concern associated with the genetic 
modification. 
The amino acid L-valine is a physiological and natural component of proteins of living organisms. 
When  consumed,  it  will  be  absorbed,  and  the  non-absorbed  fraction  will  be  incorporated  in  the 
intestinal microbial mass and excreted as such. The excess of absorbed L-valine will be excreted as 
urea/uric acid and carbon dioxide. The use of  L-valine in animal nutrition would not lead to any 
localised increase in its concentration in the environment and therefore would not pose a risk to the 
environment. 
3.5.1.  Conclusions on the safety for the environment 
The amino acid L-valine is a natural component of proteins of living organisms. Therefore, the use of 
the  highly  purified  product  L-valine,  feed  grade,  in  animal  nutrition  does  not  pose  a  risk  to  the 
environment. 
4.  Efficacy 
Efficacy studies are not required for amino acids naturally occurring in the proteins of plants and 
animals. The nutritional role of the amino acid L-valine is well established in the scientific literature. 
The product L-valine is regarded as an efficacious source of the essential amino acid L-valine for non-
ruminant animal species. 
In ruminants, the amino acid valine has been implicated as being present at lower than optimum levels 
in microbial proteins leaving the rumen (O’Connor et al., 1993; Schwab et al., 2005). Thus, when 
requirements for more limiting essential amino acids, usually L-methionine, L-lysine and L-histidine, 
have been met, L-valine supplementation could be beneficial. Free  L-valine is rapidly degraded by 
                                                       
32 Information on L-valine at ECHA website: http://apps.echa.europa.eu/registered/data/dossiers/DISS-db9bddba-e99a-1493-
e044-00144f67d031/AGGR-a5f97879-e579-446e-a8d1-ff09e760d8fc_DISS-db9bddba-e99a-1493-e044-
00144f67d031.html  L-Valine (ValAMINO
®) for all animal species 
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ruminal microbiota, with an estimated half-life in the rumen of 2.1 hours (Chalupa, 1976). Broderick 
and Balthrop (1979) found that 45 % of free L-valine added to ruminal digesta in vitro remained after 
three hours. Accordingly, only small amounts of dietary  L-valine provided to ruminants would be 
expected to reach the abomasum intact and be absorbed. Therefore, measures such as encapsulation 
would ensure a more efficient delivery of  L-valine beyond the rumen, and only limited nutritional 
benefit may be derived from dietary supplementation with the unprotected free amino acid. 
Data on the requirements, allowances and recommendations for the amino acid L-valine in different 
animal species and categories, and consequently for feed supplementation, are easily accessible in the 
standard animal nutrition literature. 
4.1.  Conclusions on efficacy 
The  additive  L-valine,  feed  grade,  produced  by  C.  glutamicum  (DSM  25202)  is  regarded  as  an 
efficacious source of the essential amino acid L-valine for all non-ruminant species. Supplemental free 
amino acid L-valine is degraded by ruminal microorganisms, if not given in a protected form. 
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
33  and  Good 
Manufacturing Practice. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Neither the production strain nor its recombinant DNA was detected in the final product. Therefore, 
the final product does not raise any safety concern with regard to the genetic modification. 
The additive  L-valine, feed grade, produced by C. glutamicum (DSM 25202) is safe for all target 
animals when supplemented in appropriate amounts to feed for a compensation of valine deficiency in 
feedingstuffs. 
Composition of tissues and products of animal origin will not be changed by the use of L-valine, feed 
grade, in animal nutrition. Considering the high purity of the product under assessment, no risks are 
expected for the consumer from its use as a feed additive. 
In the absence of any data, it would be prudent to consider L-valine produced by C. glutamicum (DSM 
25202) as an irritant to the skin, eyes and mucous membranes and as a potential dermal sensitiser. In 
the absence of any data on inhalation toxicity, the product is also regarded as potentially harmful by 
inhalation. 
The amino acid L-valine is a natural component of proteins of living organisms. Therefore, the use of 
the  highly  purified  product  L-valine,  feed  grade,  in  animal  nutrition  does  not  pose  a  risk  to  the 
environment. 
The product L-valine, feed grade, is an efficacious source of supplemented amino acid for all species 
but it has a low efficiency in ruminants unless it is used in a protected form. 
RECOMMENDATIONS 
The  description  of  the  additive  should  contain  the  statement  “produced  by  fermentation  with 
Corynebacterium glutamicum (DSM 25202)”. 
                                                       
33 Regulation  (EC)  No  183/2005  of  the  European  Parliament  and  of  the  Council  of  12  January  2005  laying  down 
requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1. L-Valine (ValAMINO
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The  production  process  should  ensure  that  microbial  contamination,  especially  for  aerobic  spore 
formers, is low. 
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APPENDIX 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed Additives on the Method(s) of Analysis for L-valine (ValAMINO
®)
34 
In  the  current  application  authorisation  is  sought  under  Article  4(1)  for  L-valine  produced  by 
Corynebacterium  glutamicum  DSM25202,  under  the  category/functional  group  3(c)  'nutritional 
additives'/'amino  acids,  their  salts  and  analogues',  according  to  Annex  I  of  Regulation  (EC)  No 
1831/2003. Authorisation is sought for all animal species. The feed additive is intended to be mixed 
either in  premixtures  or  added  directly  to  feedingstuffs.  The  Applicant  proposed  no  minimum  or 
maximum L-valine concentrations in feedingstuffs. 
For  the  determination  of  L-valine  in  feed  additive,  premixtures  and  feedingstuffs  the  Applicant 
submitted  the  Community  method  (Commission  Regulation  (EC)  No  152/2009)  further  ringtrial 
validated by CEN, resulting in the EN ISO 13903:2005 standard method. The following performance 
characteristics were reported for the determination of total valine in premixtures and feedingstuffs: - a 
relative  standard  deviation  for  repeatability  ranging  from  1.7  to  3.8  %;  and  -  a  relative  standard 
deviation for reproducibility ranging from 8.8 to 16%. 
Even  though  no  performance  characteristics  are  available  for  the  determination  of  valine  in  feed 
additive,  several  NRLs  consider  the  Community  method  suitable  for  official  control,  as  already 
recommended by the EURL in earlier reports (FAD-2007-0015; FAD-2012-0023; FAD-2012-0028). 
Furthermore, the EURL identified the "L-valine monograph" of the Food Chemical Codex (FCC), 
where identification is based on infrared absorption in combination with the analysis of the optical 
rotation, while quantification is based on titration. 
Based on the performance characteristics presented, the EURL recommends for official control the 
ring-trial validated Community method, based on ion exchange chromatography coupled with post-
column  derivatisation  and  spectrophotometric  detection  to  determine  valine  in  feed  additive, 
premixtures and feedingstuffs, and the "L-valine monograph" of the FCC for the characterisation of 
the feed additive. 
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 
 
                                                       
34 The  full  report  is  available on  the  EURL  website:  http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-
2011-0053-L-Valine.doc.pdf  